Company: WHWK
Filing Date: 2025-01-21
Form Type: PREM14A
Source: 0001193125-25-009599
Chunk: 705

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-21
Form: PREM14A
Chunk 705
---
) of
Seller, the Company or Buyer, nor have we been furnished with any such evaluation or appraisal, and we have not been asked to conduct, and did not conduct, a physical inspection of the properties or assets of Seller, the Company or Buyer.

We have assumed, at your direction, that the final executed Agreement will not differ in any respect material to our analysis or this opinion from the last
draft of the Agreement reviewed by us. We have also assumed, at your direction, that the representations and warranties made by Buyer and Seller in the Agreement and the related agreements are and will continue to be true and correct in all respects
material to our analysis. Furthermore, we have assumed, at your direction, that the Sale Transaction will be consummated on the terms set forth in the Agreement and in accordance with all applicable laws and other relevant documents or requirements,
without delay or the waiver, modification or amendment of any term, condition or agreement, the effect of which would be material to our analysis or this opinion, that, in the course of obtaining the necessary governmental, regulatory and other
approvals, consents, releases and waivers for the Sale Transaction, no delay, limitation, restriction, condition or other change will be imposed, the effect of which would be material to our analysis or this opinion, and that each of Seller, the
Company and Buyer will perform their respective covenants and agreements set forth in the Agreement in accordance with the terms of the Agreement. We have not evaluated and do not express any opinion as to the solvency or fair value of Seller, the
Company or Buyer, or their respective abilities to pay their obligations when they come due, or as to the impact of the Sale Transaction on such matters, under any state, federal or other laws relating to bankruptcy, insolvency, or similar matters.
We are not legal, regulatory, tax or accounting advisors, and we express no opinion as to any legal, regulatory, tax or accounting matters. We express no view or opinion as to the price or range of prices at which the shares of stock or other
securities or instruments of Seller or any third party may trade at any time, including subsequent to the announcement or consummation of the Sale Transaction.

We express no view as to, and our opinion does not address, Seller’s underlying business decision to proceed with or effect the Sale Transaction, or the
relative merits of the Sale Transaction as compared to any alternative business strategies or transactions that might be available to Seller or in which Seller might engage.